Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FERARO feasibility trial of capsulised fecal microbiota transplantation for eradication of antibiotic-resistant gastrointestinal carriage
2019-001618-41Phase 2Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in Multidrug-resistant Enterobacteriaceae intestinal colonization (MDREIC), Enterobacterales colonization, gastrointestinal colonization with carbapenemase-producing Enterobacterales and 1 more comparing Capsulised fecal microbiota transplantation with Placebo (2 arms). Primary endpoint: Consent rate. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Multidrug-resistant Enterobacteriaceae intestinal colonization (MDREIC)Enterobacterales colonizationgastrointestinal colonization with carbapenemase-producing Enterobacteralesbacterial disease
Beyond the preview
Go deeper on 2019-001618-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001618-41.